2004
DOI: 10.1186/1471-2490-4-14
|View full text |Cite
|
Sign up to set email alerts
|

Expression of pS2 in prostate cancer correlates with grade and Chromogranin A expression but not with stage

Abstract: Background: The biological potential of prostate cancer is extremely variable. Particular interest is focused on markers not expressed in normal prostatic tissues. pS2 protein expression has been demonstrated in a range of malignant tissues in an oestrogen-independent pathway. Recently, it has been demonstrated that pS2, in prostate cancer, is closely associated with neuro-endocrine differentiation. In the present study, we have analyzed, the potential of Neuro-endocrine and pS2 (TFF1) expression in human pros… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
10
0
1

Year Published

2006
2006
2013
2013

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 16 publications
1
10
0
1
Order By: Relevance
“…TFF1 is a prognostic marker for breast and other cancers (29,30). In agreement with previous studies, we show that the TFF1 is stimulated by estradiol and TPA in MCF-7 cells.…”
Section: Discussionsupporting
confidence: 80%
“…TFF1 is a prognostic marker for breast and other cancers (29,30). In agreement with previous studies, we show that the TFF1 is stimulated by estradiol and TPA in MCF-7 cells.…”
Section: Discussionsupporting
confidence: 80%
“…Commercial goat polyclonal Abs for COX ETC subunits II and III (Santa Cruz Biotechnology), mouse mAbs for COX ETC subunit I, and 17-kDa subunit of complex I (Mitosciences and Molecular Probes, respectively) were used as primary Abs, and respective HRP-conjugated secondary Abs (Sigma-Aldrich) were used for IHC (26). Negative control experiments were performed by using either ␥-globulin as isotype controls (Jackson ImmunoResearch Laboratories) or omission of primary Abs.…”
Section: Immunohistochemistry (Ihc)mentioning
confidence: 99%
“…A large number of studies indicate that TFF1 expression is absent or occurs at low levels in nonmalignant pancreatic and prostate tissues. Elevated expression levels of TFF1 are frequently observed in pancreatic and prostate malignancies (19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31), suggesting that TFF1 may be involved in the tumorigenesis of these cancers. These data are not, however, sufficiently convincing because of the lack of strict statistical analysis in some studies and the reduced statistical power in others with small sample sizes.…”
Section: Tff1 Expressionmentioning
confidence: 99%